EGFR nuclear translocation is stimulated by radiation mediated by Cavelolin-1 (CAV-1), and CAV-1 knockdown radiosensitizes triple-negative breast cancer, a tumor type for which there are no current targeted therapies and poor prognoses[189]. The gene discussed is CAV1; the disease is triple-negative breast carcinoma.